All stock lists
TPG RE Finance Trust, Inc. (New York Stock Exchange:TRTX)
US · Delayed Price · Currency is USD
Real Estate · REIT - Mortgage
6.42-0.07 (-1.08%)
Market cap
$487M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 20, 2017
Website
Insider Score
––Not scored
TRTX Insider Score
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
TRTX analyst forecast
TRTX analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
TRTX 12-month price target
No published price targets in the last 12 months.
TRTX ratings mix, last 12 months
Buy Hold Sell
Best analysts covering TRTX
- Wells Fargo80%success rate · +27.4% avg return · 5 calls
- JP Morgan80%success rate · +14.6% avg return · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
TRTX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-10-28 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-07-17 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-04-16 |
| — | Citizens | Market Outperform | — | — | Upgraded | 2026-03-12 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-02-19 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-19 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-10-30 |
| — | JMP Securities | Market Perform | — | — | Downgraded | 2025-09-17 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-07-31 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-05-01 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-05-01 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-04-16 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-01-21 |
| — | JP Morgan | Overweight | — | — | Upgraded | 2024-10-17 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-08-21 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2024-05-07 |
| — | Raymond James | Outperform | — | — | Downgraded | 2024-04-12 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-04-10 |
| — | B of A Securities | Underperform | — | — | Downgraded | 2024-03-04 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2024-02-22 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2023-11-30 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2023-11-03 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2023-11-02 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2023-06-13 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2023-05-12 |
| — | Citigroup | Neutral | — | — | Reiterated | 2023-05-09 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2023-05-04 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2023-04-24 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2023-02-23 |
| — | Citigroup | Neutral | — | — | Reiterated | 2023-02-23 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2022-11-03 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2022-11-03 |
| — | BTIG | Neutral | — | — | Downgraded | 2022-11-02 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2022-10-24 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2022-10-18 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2022-07-18 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2022-07-01 |
| — | Citigroup | Neutral | — | — | Reiterated | 2022-05-06 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2022-04-25 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2022-01-07 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2021-07-23 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2021-05-06 |
| — | BTIG | Buy | — | — | Reiterated | 2021-02-03 |
| — | Raymond James | Strong Buy | — | — | Upgraded | 2020-11-20 |
| — | Citigroup | Neutral | — | — | Reiterated | 2020-07-20 |
| — | Raymond James | Outperform | — | — | Reiterated | 2020-06-11 |
| — | Citigroup | Neutral | — | — | Reiterated | 2020-05-15 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2020-05-14 |
| — | Raymond James | Outperform | — | — | Reiterated | 2020-04-13 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2020-04-06 |
| — | Citigroup | Neutral | — | — | Reiterated | 2020-03-26 |
| — | Compass Point | Buy | — | — | Reiterated | 2019-12-02 |
| — | BTIG Research | Buy | — | — | Reiterated | 2018-10-09 |
| — | Wells Fargo | Outperform | — | — | Reiterated | 2018-04-16 |
| — | Raymond James | Outperform | — | — | Reiterated | 2018-03-27 |
| — | Citigroup | Neutral | — | — | Reiterated | 2017-10-17 |
| — | JMP Securities | Outperform | — | — | Reiterated | 2017-08-18 |
| — | Deutsche Bank | Buy | — | — | Reiterated | 2017-08-18 |
| — | Citigroup | Neutral | — | — | Reiterated | 2017-08-14 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2017-08-14 |
TRTX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-17 | 0.27 | 0.24 | $37.0M | $35.0M |
| 2026-04-28 | 0.25 | 0.25 | $37.1M | $37.3M |
| 2026-07-28 | 0.26 | 0.23 | $37.3M | $34.0M |
| 2026-10-26 | 0.25 | 0.07 | $37.1M | $36.0M |
| 2027-02-16Upcoming | 0.27 | — | $37.2M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.